OGN
Income statement / Annual
Last year (2024), Organon & Co.'s total revenue was $6.40 B,
an increase of 2.24% from the previous year.
In 2024, Organon & Co.'s net income was $864.00 M.
See Organon & Co.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$6.40 B |
$6.26 B |
$6.17 B |
$6.30 B |
$6.53 B |
$7.78 B |
$9.78 B |
$10.50 B |
| Cost of Revenue |
$2.69 B
|
$2.52 B
|
$2.29 B
|
$2.38 B
|
$2.12 B
|
$2.27 B
|
$4.69 B
|
$4.59 B
|
| Gross Profit |
$3.72 B
|
$3.75 B
|
$3.88 B
|
$3.92 B
|
$4.41 B
|
$5.50 B
|
$5.08 B
|
$5.91 B
|
| Gross Profit Ratio |
0.58
|
0.6
|
0.63
|
0.62
|
0.68
|
0.71
|
0.52
|
0.56
|
| Research and Development Expenses |
$469.00 M
|
$528.00 M
|
$471.00 M
|
$443.00 M
|
$210.00 M
|
$220.00 M
|
$365.00 M
|
$355.00 M
|
| General & Administrative Expenses |
$1.55 B
|
$1.68 B
|
$1.45 B
|
$1.43 B
|
$1.16 B
|
$1.18 B
|
$1.69 B
|
$1.93 B
|
| Selling & Marketing Expenses |
$206.00 M
|
$209.00 M
|
$255.00 M
|
$236.00 M
|
$198.00 M
|
$262.00 M
|
$322.00 M
|
$356.00 M
|
| Selling, General & Administrative Expenses |
$1.76 B
|
$1.89 B
|
$1.70 B
|
$1.67 B
|
$1.36 B
|
$1.44 B
|
$2.01 B
|
$2.29 B
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
-$104.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.23 B
|
$2.42 B
|
$2.18 B
|
$2.01 B
|
$1.57 B
|
$1.66 B
|
$2.38 B
|
$2.64 B
|
| Cost And Expenses |
$4.92 B
|
$4.94 B
|
$4.47 B
|
$4.39 B
|
$3.69 B
|
$3.94 B
|
$7.07 B
|
$7.23 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$19.00 M
|
$0.00
|
$11.00 M
|
| Interest Expense |
$520.00 M
|
$527.00 M
|
$422.00 M
|
$258.00 M
|
$6.00 M
|
$6.00 M
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$277.00 M
|
$236.00 M
|
$212.00 M
|
$195.00 M
|
$142.00 M
|
$354.00 M
|
$1.67 B
|
$1.97 B
|
| EBITDA |
$1.60 B |
$1.44 B |
$1.76 B |
$1.98 B |
$2.99 B |
$3.92 B |
$4.38 B |
$5.08 B |
| EBITDA Ratio |
0.25
|
0.23
|
0.28
|
0.31
|
0.46
|
0.5
|
0.45
|
0.48
|
| Operating Income Ratio |
0.23
|
0.21
|
0.28
|
0.3
|
0.44
|
0.49
|
0.28
|
0.31
|
| Total Other Income/Expenses Net |
-$679.00 M
|
-$654.00 M
|
-$583.00 M
|
-$386.00 M
|
-$95.00 M
|
-$144.00 M
|
$23.00 M
|
-$173.00 M
|
| Income Before Tax |
$807.00 M
|
$673.00 M
|
$1.12 B
|
$1.53 B
|
$2.75 B
|
$3.70 B
|
$2.73 B
|
$3.10 B
|
| Income Before Tax Ratio |
0.13
|
0.11
|
0.18
|
0.24
|
0.42
|
0.48
|
0.28
|
0.3
|
| Income Tax Expense |
-$57.00 M
|
-$350.00 M
|
$205.00 M
|
$178.00 M
|
$496.00 M
|
$390.00 M
|
$576.00 M
|
$1.30 B
|
| Net Income |
$864.00 M
|
$1.02 B
|
$917.00 M
|
$1.35 B
|
$2.16 B
|
$3.22 B
|
$2.15 B
|
$1.80 B
|
| Net Income Ratio |
0.13
|
0.16
|
0.15
|
0.21
|
0.33
|
0.41
|
0.22
|
0.17
|
| EPS |
3.36 |
4.01 |
3.61 |
5.33 |
8.52 |
12.71 |
8.51 |
7.11 |
| EPS Diluted |
3.33 |
3.99 |
3.59 |
5.33 |
8.52 |
12.71 |
8.51 |
7.11 |
| Weighted Average Shares Out |
$257.05 M
|
$255.24 M
|
$254.08 M
|
$253.55 M
|
$253.52 M
|
$253.13 M
|
$253.13 M
|
$253.13 M
|
| Weighted Average Shares Out Diluted |
$259.15 M
|
$256.27 M
|
$255.17 M
|
$253.55 M
|
$253.52 M
|
$253.13 M
|
$253.13 M
|
$253.13 M
|
| Link |
|
|
|
|
|
|
|
|
